期刊文献+

心房颤动门诊病例的调查

Investigation of Outpatients With Atrial Fibrillation
下载PDF
导出
摘要 探讨心房颤动(简称房颤)门诊病例的临床特点、伴随疾病、治疗情况和血栓栓塞并发症的患病率.收集2003年7月至2003年10月来我院门诊就诊的270例房颤患者的病例资料,登记患者的人口学特征、临床特点、伴随疾病、抗凝治疗和抗心律失常药物治疗情况以及血栓栓塞并发症的发生情况,观察房颤的发病特点和治疗情况.在270例房颤中,男147例,占54.4%;患者年龄62.0±10.1岁.其中阵发性房颤93例,占34.4%,慢性房颤177例,占65.6%.瓣膜性房颤85例,占31.5%,瓣膜性房颤和非瓣膜性房颤(NVAF)患者中,血栓栓塞性疾病的患病率分别为9.4%和9.2%.瓣膜性房颤患者华法林的应用率为95.3%,合并血栓栓塞危险因素的NVAF患者华法林应用率为23.4%,应用华法林的患者就诊时国际标化率<2.0的占57.6%.阵发性房颤患者抗心律失常药物的应用率为38.7%,胺碘酮可引发甲状腺机能紊乱.结论:门诊房颤患者以老龄患者为主,NVAF患者血栓栓塞事件的发生率高,华法林的应用率低,阵发性房颤患者应用抗心律失常药物不良反应发生率较高.
出处 《中国心脏起搏与心电生理杂志》 2004年第z1期189-,共1页 Chinese Journal of Cardiac Pacing and Electrophysiology
  • 相关文献

参考文献6

  • 1戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380
  • 2FUSTER V;Ryde'n LE;Asinger RW.ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guid[J],2001.
  • 3Kannel WB;Wolf PA;Benjamin EJ.Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates[J],1998(8A).
  • 4马长生,周玉杰,马煜,郑知刚,颜红兵,王勇,李霄,柯元南,汤旦林.北京地区非瓣膜病心房颤动患者缺血性脑卒中发生率及影响因素的随访研究[J].中华心血管病杂志,2002,30(3):165-167. 被引量:148
  • 5Petersen P.Thromboembolic complications in atrial fibrillation,1990.
  • 6The AFFIRM investigators.A comparison of rate control and rhythm control in patients with atrial fibrillation[J],2002(23).

二级参考文献10

  • 1Saoudi N,Schoels W,EL-Sherif N,eds.Atrial flutter and fibrillation:from basic to clinical applications[]..1998
  • 2Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke: the Framingham study[].Stroke.1991
  • 3Caro JJ,Flegel KM,Orejuela ME,et al.Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice[].Canadian Medical Association Journal.1999
  • 4Flegel KM,Shipley MJ,Rise G.Risk of stroke in non-rheumatic atrial fibrillation[].The Lancet.1987
  • 5Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation[].Stroke.2000
  • 6Hart RG,Sherman DG,Easton JD,et al.Prevention of stroke in patients with nonvalvular atrial fibrillation[].Neurology.1998
  • 7Peterson P,Boysen G,Godtfredsen J,et al.Placebo controlled,randomized trial of warfarin and aspirin for prevention of thromboembolic complications on chronic atrial fibrillation: the Compenhagen AFASAK study[].The Lancet.1989
  • 8Feinberg WM,Blackshear JL,Laupacis A,et al.Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications[].Archives of Internal Medicine.1995
  • 9Ezekowitz MD,Bridgers SL,James KE,et al.Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation:Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators[].The New England Journal of Medicine.1992
  • 10Connolly SJ,Laupacis A,Gent M,et al.Canadian atrial fibrillation anticoagulation (CAFA) study[].Journal of the American College of Cardiology.1991

共引文献481

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部